Filing Details
- Accession Number:
- 0000911916-16-000579
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-07 16:25:01
- Reporting Period:
- 2016-06-05
- Filing Date:
- 2016-06-07
- Accepted Time:
- 2016-06-07 16:25:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1348649 | Colucid Pharmaceuticals Inc. | CLCD | Pharmaceutical Preparations (2834) | 203419541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1639978 | P. Thomas Mathers | C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-05 | 3,756 | $0.00 | 250,156 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-06 | 1,502 | $7.25 | 248,654 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2016-06-05 | 3,756 | $0.00 | 3,756 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
131,434 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of CoLucid Pharmaceuticals, Inc. common stock.
- Includes 5,000 shares acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan between December 1, 2015 and May 31, 2016.
- Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Mathers on March 11, 2016.
- Represents the sale of 1,502 shares in multiple transactions, ranging in price from $7.18 to $7.27 per share, resulting in a weighted average sale price of $7.2463. The reporting person will provide, upon request bythe SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- On May 5, 2015, the reporting person received 360,508 RSUs. Those RSUs vest as follows: 50% of the RSUs vested on November 5, 2015; 12.5% of the RSUs vested on May 5, 2016; and the remaining RSUs vest in aseries of 36 successive equal monthly installments upon completion of each additional month of service.